SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike
With the ongoing pandemic, it is critical to understand how natural immunity against SARS-CoV-2 and COVID-19 develops. We have identified that subjects with more severe COVID-19 disease mount a more robust and neutralizing antibody response against SARS-CoV-2 spike protein.
Guardado en:
Autores principales: | Jenna J. Guthmiller, Olivia Stovicek, Jiaolong Wang, Siriruk Changrob, Lei Li, Peter Halfmann, Nai-Ying Zheng, Henry Utset, Christopher T. Stamper, Haley L. Dugan, William D. Miller, Min Huang, Ya-Nan Dai, Christopher A. Nelson, Paige D. Hall, Maud Jansen, Kumaran Shanmugarajah, Jessica S. Donington, Florian Krammer, Daved H. Fremont, Andrzej Joachimiak, Yoshihiro Kawaoka, Vera Tesic, Maria Lucia Madariaga, Patrick C. Wilson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/795af7997c9f4b069f3284b32db263f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An Egg-Derived Sulfated
<i>N</i>
-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines
por: Jenna J. Guthmiller, et al.
Publicado: (2021) -
Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Yuko Sakai-Tagawa, et al.
Publicado: (2021) -
Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.
por: S Kyle Austin, et al.
Publicado: (2012) -
Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC
por: Jessica S. Donington, MD
Publicado: (2021) -
Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
por: Tadashi Maemura, et al.
Publicado: (2021)